Article ; Online: Pharmacological approaches to target type 2 cytokines in asthma.
2022 Volume 237, Page(s) 108167
Abstract: Asthma is the most common chronic lung disease, affecting more than 250 million people worldwide. The heterogeneity of asthma phenotypes represents a challenge for adequate assessment and treatment of the disease. However, approximately 50% of asthma ... ...
Abstract | Asthma is the most common chronic lung disease, affecting more than 250 million people worldwide. The heterogeneity of asthma phenotypes represents a challenge for adequate assessment and treatment of the disease. However, approximately 50% of asthma patients present with chronic type 2 inflammation initiated by alarmins, such as IL-33 and thymic stromal lymphopoietin (TSLP), and driven by the T |
---|---|
MeSH term(s) | Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Asthma ; Cytokines/metabolism ; Humans |
Chemical Substances | Antibodies, Monoclonal ; Cytokines |
Language | English |
Publishing date | 2022-03-10 |
Publishing country | England |
Document type | Journal Article ; Review ; Research Support, Non-U.S. Gov't |
ZDB-ID | 194735-7 |
ISSN | 1879-016X ; 0163-7258 |
ISSN (online) | 1879-016X |
ISSN | 0163-7258 |
DOI | 10.1016/j.pharmthera.2022.108167 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1183: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.